Current studies have consistently shown that people taking the newest GLP medications can expect to lose around 15% to 20% of their body weight over the course of 68 weeks
If tirzepatide gets approved for additional indications like NASH, sleep apnea, CKD, heart failure, pre-diabetes, etc., it could significantly increase the market opportunity for Eli Lilly
Our patients use peptide therapy for body composition optimization, recovery acceleration after injury or training, sexual health support, appetite and weight regulation, cognitive performance, anxiety support, and anti-aging protocols
Indeed, genetic and pharmacological replenishment of NAD + improves the age-related biologic function and increases lifespan at least in worms and mice
Your provider adjusts your dose as your treatment progresses
Horber FF, Steffen R